advertisement
11.14 Investigational drugs; pharmacological experiments (12)
Showing records 1 to 12
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments18202 Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis
Yam GH; Gaplovska-Kysela K; Zuber C; Roth J
Investigative Ophthalmology and Visual Science 2007; 48: 1683-1690
17455 Analysis of human carbonic anhydrase II: Docking reliability and receptor-based 3D-QSAR study
Tuccinardi T; Nuti E; Ortore G; Supuran CT; Rossello A; Martinelli A
Journal of Chemical Information and Modeling 2007; 47: 515-525
17633 Implication of cannabinoids in neurological diseases
Alsasua del Valle A
Cellular and molecular neurobiology 2006; 26: 579-591
17567 Structure-activity relationships, and drug metabolism and pharmacokinetic properties for indazole piperazine and indazole piperidine inhibitors of ROCK-II
Feng Y; Cameron MD; Frackowiak B; Griffin E; Lin L; Ruiz C; Schroter T; LoGrasso P
Bioorganic and Medicinal Chemistry Letters 2007; 17: 2355-2360
17568 Carbonic anhydrase inhibitors: Binding of an antiglaucoma glycosyl-sulfanilamide derivative to human isoform II and its consequences for the drug design of enzyme inhibitors incorporating sugar moieties
Fiore AD; Scozzafava A; Winum J-Y; Montero J-L; Pedone C; Supuran CT; De Simone G
Bioorganic and Medicinal Chemistry Letters 2007; 17: 1726-1731
17648 Synthesis and ocular hypotensive activity of magnolol
Huang W-H; Lin I-H; Tan K-I; Chiang C-H; Lee A-R
Chinese Pharmaceutical Journal 2006; 58: 115-122
17622 New ocular therapeutics: a view from the patenting perspective
Mucke HA
Idrugs 2007; 10: 37-41
18096 The IOP-lowering effects and mechanism of action of tafluprost in prostanoid receptor-deficient mice
Ota T; Aihara M; Saeki T; Narumiya S; Araie M
British Journal of Ophthalmology 2007; 91: 673-676
17608 Pigment epithelium-derived factor protects retinal ganglion cells
Pang I-H; Zeng H; Fleenor DL; Clark AF
BMC Neuroscience 2007; 8: 11
17529 AL-34662: A potent, selective, and efficacious ocular hypotensive serotonin-2 receptor agonist
Sharif NA; McLaughlin MA; Kelly CR
Journal of Ocular Pharmacology and Therapeutics 2007; 23: 1-13
18169 The Rho-kinase inhibitor H-1152P suppresses the wound-healing activities of human Tenon's capsule fibroblasts in vitro
Tura A; Grisanti S; Petermeier K; Henke-Fahle S
Investigative Ophthalmology and Visual Science 2007; 48: 2152-2161
17601 Experimental study of TGF-β(2) antisense oligodeoxynucleotide as an anti-scarring agent in glaucoma surgery
Li J-Y; Fu P; Yang Q
International Journal of Ophthalmology 2007; 7: 10-14
